Skip to main content

CITADEL ADVISORS LLC

Position in PRLD — Prelude Therapeutics Inc

CIK 1423053 MIAMI, FL

Position in PRLD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$425,372
+$398,170 QoQ
Shares Held
124,378
+269.9% QoQ
Ownership
0.156%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRLD Over Time

Shares Held

Position Value (USD)

Derivatives in PRLD

reported options exposure · as of Mar 31, 2025
CallValue
$18,355
CallShares
23,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. PRLD ranks #266 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRLD

Export CSV
34 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $425,372 124,378
2025-06-30 $27,202 33,625
2025-03-31 $18,355 23,900
2025-03-31 $26 34
2024-12-31 $13,128 10,297
2024-12-31 $8,160 6,400
2024-09-30 $1,035 500
2024-09-30 $621 300
2024-09-30 $31,515 15,225
2024-06-30 $119,588 31,388
2024-06-30 $1,524 400
2024-06-30 $381 100
2024-03-31 $948 200
2024-03-31 $141,228 29,795
2023-12-31 $2,989 700
2023-12-31 $4,270 1,000
2023-12-31 $407,058 95,330
2023-09-30 $3,708 1,200
2023-09-30 $927,311 300,101
2023-09-30 $618 200
2023-06-30 $5,400 1,200
2023-06-30 $165,910 36,869
2023-06-30 $2,250 500
2022-12-31 $604 100
2022-12-31 $110,121 18,232
2022-09-30 $959,772 145,200
2022-09-30 $104,000 15,734
2022-06-30 $1,551,384 297,200
2022-06-30 $572,231 109,623
2022-03-31 $351,196 50,898
2022-03-31 $1,182,660 171,400
2021-12-31 $1,724,324 138,500
2021-09-30 $452,968 14,495
2020-09-30 $3,341,868 110,915